Page last updated: 2024-09-04

celastrol methyl ester and [2-(1-piperidinyl)-1,3-benzothiazol-6-yl]-[4-(2-pyridinyl)-1-piperazinyl]methanone

celastrol methyl ester has been researched along with [2-(1-piperidinyl)-1,3-benzothiazol-6-yl]-[4-(2-pyridinyl)-1-piperazinyl]methanone in 1 studies

Compound Research Comparison

Studies
(celastrol methyl ester)
Trials
(celastrol methyl ester)
Recent Studies (post-2010)
(celastrol methyl ester)
Studies
([2-(1-piperidinyl)-1,3-benzothiazol-6-yl]-[4-(2-pyridinyl)-1-piperazinyl]methanone)
Trials
([2-(1-piperidinyl)-1,3-benzothiazol-6-yl]-[4-(2-pyridinyl)-1-piperazinyl]methanone)
Recent Studies (post-2010) ([2-(1-piperidinyl)-1,3-benzothiazol-6-yl]-[4-(2-pyridinyl)-1-piperazinyl]methanone)
39027601

Protein Interaction Comparison

ProteinTaxonomycelastrol methyl ester (IC50)[2-(1-piperidinyl)-1,3-benzothiazol-6-yl]-[4-(2-pyridinyl)-1-piperazinyl]methanone (IC50)
TPA: protein transporter TIM10Saccharomyces cerevisiae S288C46.1

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, K; Ding, X; Jiang, H; Luo, C; Luo, X; Xiong, F; Xu, H; Zhang, H1

Other Studies

1 other study(ies) available for celastrol methyl ester and [2-(1-piperidinyl)-1,3-benzothiazol-6-yl]-[4-(2-pyridinyl)-1-piperazinyl]methanone

ArticleYear
Discovery of novel reversible monoacylglycerol lipase inhibitors via docking-based virtual screening.
    Bioorganic & medicinal chemistry letters, 2021, 06-01, Volume: 41

    Topics: Animals; Anti-Inflammatory Agents; Cytokines; Dose-Response Relationship, Drug; Drug Discovery; Drug Evaluation, Preclinical; Enzyme Inhibitors; Lipopolysaccharides; Mice; Molecular Docking Simulation; Molecular Structure; Monoacylglycerol Lipases; RAW 264.7 Cells; RNA, Messenger; Structure-Activity Relationship

2021